Coronavirus business update Get 30 days’ complimentary access to our Coronavirus Business Update newsletter 30 days complimentary
Add this topic to your myFT Digest for news straight to your inbox
Move comes as FDA gives emergency authorisation for use of plasma from recovered patients
Employers who check staff could be allowed to stay open even under local lockdown restrictions, according to talks
University of Hong Kong says 33-year-old man caught virus in March and again in August
Private equity group hopes transaction will prompt flurry of similar deals in Japan
The pandemic highlights how inequality ultimately harms the well-being of the wealthy as well as the disadvantaged
Companies warn current regulations will encourage investment to shift elsewhere in Europe
Unpredictable juries expose potential hazards of German conglomerate’s approach
US concerns that Trump will rush to approve a vaccine before election is playing into wider safety fears
Tie-up is latest example of big pharma seeking to bolster rare disease portfolio
The sale of subsidiary will help the Japanese pharmaceutical to bring down leverage
Middle of a pandemic is not the time for a major UK health reorganisation
Covax scheme aims to distribute 2bn vaccines but has struggled to raise funds
National Institute for Health Protection will take in NHS tracing programme and biosecurity centre
US pharma group says Britain is ‘world leader’ in developing science
Patient backlog expected to reach 10m by Christmas after services interrupted by Covid
As the French group tries to reduce dependence on some drugs, bolt-on deals make sense
Chief Paul Hudson’s strategy aims to shift focus to therapies for rarer diseases
Companies that have tapped wellness industry receive boost as more people take supplements
International Edition